[Insightec in PR Newswire] INSIGHTEC Receives FDA Approval to Initiate Clinical Study of MR-Guided Focused Ultrasound to Treat Patients With Alzheimer’s Disease

INSIGHTEC, a global medical technology innovator of incisionless surgery, today announced that the U.S. Food and Drug Administration (FDA) has approved the initiation of a clinical study using the company’s MR-guided Focused Ultrasound (MRgFUS) to treat patients with Alzheimer’s disease (AD).

Read more on PR Newswire here.